These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8093650)

  • 21. In situ RT-PCR detection of Epstein-Barr virus immediate-early transcripts in CD4+ and CD8+ T lymphocytes.
    Guan M; Romano G; Henderson EE
    Anticancer Res; 1998; 18(5A):3171-80. PubMed ID: 9858880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China.
    Ji KM; Li CL; Meng G; Han AD; Wu XL
    Arch Virol; 2008; 153(10):1949-53. PubMed ID: 18807115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.
    Lu CC; Jeng YY; Tsai CH; Liu MY; Yeh SW; Hsu TY; Chen MR
    Virology; 2006 Feb; 345(2):358-72. PubMed ID: 16298410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the expression of the Epstein-Barr virus early gene BFRF1.
    Granato M; Farina A; Gonnella R; Santarelli R; Frati L; Faggioni A; Angeloni A
    Virology; 2006 Mar; 347(1):109-16. PubMed ID: 16406456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
    Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM
    J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H2O2 inhibits BCR-dependent immediate early induction of EBV genes in Burkitt's lymphoma cells.
    Osipova-Goldberg HI; Turchanowa LV; Adler B; Pfeilschifter JM
    Free Radic Biol Med; 2009 Oct; 47(8):1120-9. PubMed ID: 19540913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways of activation of the Epstein-Barr virus productive cycle.
    Sinclair AJ; Brimmell M; Shanahan F; Farrell PJ
    J Virol; 1991 May; 65(5):2237-44. PubMed ID: 1850009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1.
    Hicks MR; Balesaria S; Medina-Palazon C; Pandya MJ; Woolfson DN; Sinclair AJ
    J Virol; 2001 Jun; 75(11):5381-4. PubMed ID: 11333921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
    J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus transcription factors.
    Sinclair AJ; Farrell PJ
    Cell Growth Differ; 1992 Aug; 3(8):557-63. PubMed ID: 1327084
    [No Abstract]   [Full Text] [Related]  

  • 33. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
    Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
    Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
    Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances on zeta protein encoded by Epstein-Barr virus (EBV) BZLF1 gene].
    Wang H; Cao Y
    Ai Zheng; 2003 Oct; 22(10):1105-9. PubMed ID: 14558963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphohistiocytosis.
    Imajoh M; Hashida Y; Murakami M; Maeda A; Sato T; Fujieda M; Wakiguchi H; Daibata M
    J Med Virol; 2012 Jun; 84(6):940-6. PubMed ID: 22511310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas.
    Yang Y; Jia Y; Wang Y; Wang X; Sun Z; Luo B
    J Med Virol; 2014 Oct; 86(10):1788-95. PubMed ID: 24615673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.
    Ye J; Gradoville L; Miller G
    J Virol; 2010 Dec; 84(23):12405-18. PubMed ID: 20861250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and expression of a spliced variant of Epstein-Barr virus bzlf1 and preparation of its polyclonal antibody.
    Qian L; Li D; Yang Z; Hu M; Yu M; Shi M; Shen B; Guo N
    Prep Biochem Biotechnol; 2010; 40(1):46-56. PubMed ID: 20024794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus SM protein.
    Cook ID; Shanahan F; Farrell PJ
    Virology; 1994 Nov; 205(1):217-27. PubMed ID: 7975218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.